Home News Current Technicals: Ebix (NASDAQ: EBIX)

Current Technicals: Ebix (NASDAQ: EBIX)

20
0
SHARE

Ebix trades as part of the technology sector and application software industry. The company CEO is Robin Raina. Ebix Inc provides software and e-commerce solutions to the insurance, finance and healthcare industries.

Previous Intraday Trading Performance:

The EBIX stock showed a previous change of 1.61% with an open at 45.54 and a close of 46.00. It reached an intraday high of 46.28 and a low of 45.21.

SeekingAlpha:  EbixCash to acquire India-based Essel Forex

Liquidity:

The stock has a market cap of $7.2b with 156.4m shares outstanding, of which the float is 149.0m shares. Trading volume reached 254,762 shares compared to its average volume of 502,737 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Ebix shares returned 8.41% and in the past 30 trading days it returned -7.00%. Over three months, it changed -27.34%. In one year it has changed -42.85% and within that year its 52-week high was 89.10 and its 52-week low was 39.27. EBIX stock is 17.14% above its 52 Week Low.

Our calculations show a 200 day moving average of 69.37 and a 50 day moving average of 48.33. Currently EBIX stock is trading -33.69% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

SeekingAlpha:  EbixCash to acquire India-based Essel Forex

Earnings:

The last annual fiscal EPS for the company was reported at 3.17 that ended on 31st of December 2017, which according to the previous close, that is a PE of 14.51. The TTM EPS is 0.00, which comes to a TTM PE of 0.00.

The following are the last four quarter reported earnings per share:
09-30-2018:  0.92
06-30-2018:  0.92
03-31-2018:  0.83
12-31-2017:  0.84

The dividend per share is currently 0.30, which is a dividend yield of 0.65%.

Base on our calculations, the intrinsic value per share is 57.23, which means it is possibly undervalued and has a margin of safety of 19.63%

Indicators to Watch:

Based on the latest filings, there is 121.40% of institutional ownership. Short-interest is 0, which is 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio is 0.00.

The current calculated beta is 1.45

SeekingAlpha:  Diplomat Pharmacy says two execs depart as CastiaRx unit disappoints

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 23.36%, return on assets is 9.10%, profit margin is 23.46%, price-to-sales is 19.58 and price-to-book is 2.76.

Company Scores:

All scores are out of six:
 4  :Valuation Score
 2  :Past Performance Score
 2  :Financial Strength Score
 4  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.